Right. Thats great news!

Bummer about all that lost profit. Better luck next time!

David Koos is a criminal plain and simple. I am sorry for your losses. You were not Don McGregors only victim.

Comparing Koos to Henry Ford is apples to oranges. Tell Don Hi from Joe!

Dr. Koos past performance

Chairman, President, CEO and Acting CFO Bio-Matrix Scientific Group, Inc.

A joke. It trades sub penny down from 3.50's. Income statement:

finance.yahoo.com/q/is?s=bmsn.pk

BMSN brags of owning ~50% of ENTB and 10% BMXP Holdings (see below)


Chairman, CEO, Secretary & Acting CFO Frezer Inc.

No longer exists. Looks like even Koos lost some money here.

openinsider.com/FRZR

Chairman, CEO & Acting CFO BMXP Holdings, Inc.

Gone.

Managing Director & President Cell Source Research Inc.

I can't find anything current here so I think it is safe to assume it failed to.


Managing Director & President Venture Bridge Inc.

There is a link to Manta and this:

investing.businessweek.com/research/stocks/people/person.asp?personId=13155115&ticker=ENTB:US

I love the number of titles he has at ENTB. Ran everyone off did he?

Chairman of the Board of Directors, CFO & Secretary Cell Bio-Systems Inc(New York).

I give up.

Registered Representative Amerivet Securities Inc.

Hey buddy. Still riding this to the moon?

Thats really not true unless you are inside trading or there is a conflict of interest. CEO, president, board of director/ entire board types are legitimate targets. As far as any comments being able to be put back up, thats not true either if their is a TOS violation such as a personal attack on a board member. FYI

Your lawyer? Why not the SEC?

Hopefully chartinator and matto join him.

based on what indicator(s)?

This is not a low floater anymore.

I thought I read ENTB was going to 15

There is no big news other than more bad news coming from this company. They do no science. They have never used stem cells for their own research. It was a scam. So play it bit don't stay in it because Koos is laughing at anyone who does.

And who would get on board with a chump like Koos? He has run a long line of businesses into the ground.

Bet your buddies at Stock Seasonality and STC aren't saying a word about the pps are they? I notice the ghost of koos isnt posting anymore either. Lights out.

I went back through our dialogue... so now they are saying they will get funded to exploit studies with humans instead of seeking to get funding for clinics. Still a joke. Good luck though.

Are you basing your buy on BMSN news? I don't doubt it will bounce some but its still a POS.

Thats money. Good one.

That news is a joke. Note they were funded to bring 1 of 30 treatments to market. Well which? And in humans? Look at David Koos past. He has not succeeded once. see how many biotechs he has failed. Look at the dog studies. Didn't happen. Now the leap to humans. This is good for a flip. Don't get attached.

Get in get out unless something substantial happens. If BMSN or Koos were for real as in a real company that actually has a product then this stock would trade for dollars not pennies. Be careful.

ENTB is still a scam. They lied, they stole, and cheated. There is no reason to buy this company. Do your DD if you are new to this stock. GL

A sure sign of a stable, growing business with a plan.

ENTB validated.

Right after the R/S they could go above a penny. Its true.

Wait. Chart consolidating? lol

You do not KNOW Asher is shorting. That's a guess on your part.

LOL. R/S is never good. I bet your buddy at STC told you it would never happen. ENTB was always a farce. They never even did any science.

Greed kills.

What happened to all of the information that shows ENTB is not a scam?

I understand your perspective but the fact that there are no other members on a board that was once plural in its membership does not look good. Its quite negative actually.

How about the feline studies? And what about your emails with Koos?

Excuses for ENTB:

1. Koos does not need a board of directors because he is a Nevada corp.

2. They are not diluting because the millions of shares entering the float are from convertibles not the company (ASHER). Really? Dilution is dilution in any form that it comes. I won't paste a link to wikipedia that defines dilution.

3.They don't have enough money for their study. This is a favorite. Apparently some poster talked to Koos and Koos said money was tight.

4. Oregon clinic is gone even though its presence was used as a defense of ENTB's greatness.

5. Asher is shorting. Hmmm, and now that they are done shorting they are selling, as in #2 above, according to one poster. Read the contradictions.

Bye ENTB.

And that is why this is a lottery play. Right?

Too funny. What will be the next excuse for ENTB?

I guess ENTB has a flat tire? Maybe a set?

Good call on ENTB

The more I read this PR the less important it seems. When will ENTB do something on its own? This is news for MEDS not ENTB.

Do you think that really instills an ounce of confidence around here at this point? You know as well as I there is no real way to look at the share structure at this juncture. We have no idea how many shares Koos, BMSN, etc have, nor what has entered the float. Been blaming Asher for the pps for how long?

ENTB does no research or science. They help MEDS. That's it. They wouldn't know a stem cell from a squamous cell.

Well said.

LOL. Wishful thinking.